Aggressiveness in cholesterol granuloma of the temporal bone may be determined by the vigor of its blood source

Related Experiment Video

Updated: Jul 17, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Markus H F Pfister1, Robert K Jackler, Larisa Kunda

  • 1Department of Otolaryngology, University of Tuebingen, Germany.

Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology
|January 27, 2007
PubMed

Insights

Aggressive cholesterol granuloma (CG) in the mastoid is linked to nearby blood vessels. This suggests ongoing hemorrhage from these vascular sources fuels the aggressive behavior of mastoid CG.

Area of Science:

  • Otolaryngology
  • Neurosurgery
  • Pathology

Background:

  • Cholesterol granuloma (CG) typically presents as indolent in the lateral temporal bone.
  • Aggressive behavior in CG, particularly in the petrous apex, has been linked to vascular proximity.
  • The factors driving atypical aggression in mastoid CG require further investigation.

Observation:

  • This study examined four cases of atypically aggressive mastoid CG.
  • All cases demonstrated the cholesterol granuloma abutting a significant blood supply.

Findings:

  • The identified vascular sources included the sigmoid sinus, carotid artery, a large dural vein, and vascular marrow in the mastoid tip.
  • These findings support the hypothesis that proximity to a rich blood source is crucial for aggressive CG behavior.

Implications:

  • The results reinforce the theory that sustained hemorrhage from adjacent vascular structures is the primary driver of aggressive cholesterol granuloma.
  • Understanding this relationship is vital for managing aggressive mastoid CG and preventing complications.
Abstract

More Related Videos

Computed Tomography and Optical Imaging of Osteogenesis-angiogenesis Coupling to Assess Integration of Cranial Bone Autografts and Allografts13:16

Computed Tomography and Optical Imaging of Osteogenesis-angiogenesis Coupling to Assess Integration of Cranial Bone Autografts and Allografts

Published on: December 22, 2015

Related Concept Videos

Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Blood and Nerve Supply to the Bones01:29

Blood and Nerve Supply to the Bones

Bones are dynamic organs that require a rich supply of oxygen and nutrients. Around 5% to 10% of the cardiac output supplies blood to the bones. A typical long bone has three main sources: the nutrient artery, the metaphyseal and epiphyseal arteries, and the periosteal arteries.
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...